Rapid whole blood assay for HIV-1 seropositivity using an Fab-peptide conjugate☆

Add time:08/28/2019    Source:sciencedirect.com

A rapid whole blood test has been developed for circulating antibodies to human immunodeficiency virus type 1 (HIV-1), based on agglutination of autologous red blood cells. Evaluation of the test revealed that 100% of seropositive HIV-1 patients (both asymptomatic and AIDS cases) were detected (n = 94) with a specificity of 99.5% in healthy blood donors (n = 596). The assay uses an Fab fragment of a monoclonal antibody specifically directed against glycophorin (a transmembrane glycoprotein present on the surface of human red blood cells). This anti-red blood cell Fab is conjugated via the inter-heavy chain cysteines to a synthetic peptide corresponding to the immunodominant epitope of the HIV-1 viral coat protein gp41 (579–613). Addition of this reagent to 10 μl of whole blood results in the Fab-peptide conjugate coating the red blood cells with peptide. In the presence of circulating antibodies to the HIV-1 peptide, red cell agglutination occurs within 2 min. The sensitivity and specificity of this reagent indicate that it is appropriate for use as a rapid diagnostic test for HIV-1 seropositivity.

We also recommend Trading Suppliers and Manufacturers of HIV ENVELOPE PROTEIN (GP41) FRAGMENT 579-601 (cas 117137-84-5). Pls Click Website Link as below: cas 117137-84-5 suppliers

Prev:Human Complement Proteins C3b, C4b, Factor H and Properdin React with Specific Sites in gpl20 and gp4l, the Envelope Proteins of HIV1
Next:The human immunodeficiency virus-1 envelope protein gp120 binds through its V3 sequence to the glycine site of N-methyl-d-aspartate receptors mediating noradrenaline release in the hippocampus)